Topical treatment of Sjögren-Larsson syndrome with calcipotriol

G P Lucker; P C van de Kerkhof; J R Cruysberg; D J der Kinderen; P M Steijlen

doi:10.1159/000246719

Topical treatment of Sjögren-Larsson syndrome with calcipotriol

Dermatology. 1995;190(4):292-4. doi: 10.1159/000246719.

Authors

G P Lucker¹, P C van de Kerkhof, J R Cruysberg, D J der Kinderen, P M Steijlen

Affiliation

¹ Department of Dermatology, University Hospital, Nijmegen, The Netherlands.

PMID: 7655108
DOI: 10.1159/000246719

Abstract

Two patients with Sjögren-Larsson syndrome were treated with calcipotriol in ointment and the ointment base only for 12 weeks, using a double-blind bilaterally paired comparative study. Unilateral improvement was observed in both patients in favour of the calcipotriol-treated side. The present case is the first demonstration of a substantial clinical effect of calcipotriol in the Sjögren-Larsson syndrome.

Publication types

Case Reports
Clinical Trial
Controlled Clinical Trial
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Calcitriol / administration & dosage
Calcitriol / analogs & derivatives*
Calcitriol / therapeutic use
Dermatologic Agents / administration & dosage
Dermatologic Agents / therapeutic use*
Double-Blind Method
Female
Humans
Male
Ointments
Sjogren-Larsson Syndrome / drug therapy*

Substances

Dermatologic Agents
Ointments
calcipotriene
Calcitriol